In today’s health care environment, doctors are being pushed to their limits to provide the very best care while keeping their practice healthy. Novartis needed a way for their pharma reps to target these practices in a way that placed less stress on the doctors. The solution to this issue came in the form of a series of influence programs for the practice nurse. These programs were such an immediate success that Novartis implemented them across all of their oncology drugs.
This same group also marketed Exjade, a drug targeting the problems associated with sickle cell anemia. Many sufferers have difficulty obtaining consistent care, which is dangerous because the treatment, blood transfusions, can lead to life-threatening complications. Patients, especially those with unreliable treatment records, can suffer from a deadly transfusion-related condition known as iron overload. Novartis launched a patient education strategy in the form of a grass roots program that reached out to heavily affected communities through local events offering testing, education, and reasons to learn. Piloted in Atlanta, the success of the program convinced Novartis to expand reach into 15 additional cities.
Storytelling is how we articulate the brand in human terms. It reveals the relevant and compelling connection between a brand and its customers. And it sparks belief that ultimately changes behavior. As marketers, we can choose to make the story interesting and informational, or we can decide to make it epic.
We all start with a blank page. Before making a single mark, we collect the data, essential information that allows us to make the very best choices in planning the correct approach in crafting the strongest story.
When research guides the message and is written and designed to influence in a highly personalized manner, a story will resonate with a commanding voice that will create sustainable results.
The story we tell today could very well be the first volume of a long run for your brand. Through examining the future possibilities of the therapies, we can begin to envision the opportunities the brand may have as it matures and create campaigns that allow for expansion.
Every drug or medical device has a three-part story that begins with the science, evolves into the clinical, and ultimately becomes the story from which you launch, or the commercial story. Epic has been an effective partner in assisting across this continuum.
Although various audiences have unique information requirementsconcerning your product, Epic provides unified solutions that are expansive in their ability to address diverse concerns while upholding brand identity.
At Epic, we deploy a thorough process in translating the positioning to the ultimate campaign, exploring every attribute of the brand and its potential relationship with the audience.
There is no “B” team here at Epic. Every one that is part of our team has a rich history of success that is evident in all that we do. Experience is our greatest asset.
Thought leadership can both validate the path we’ve chosen in our marketing efforts or inspire us to think beyond what we considered possible.